-
公开(公告)号:US20150258277A1
公开(公告)日:2015-09-17
申请号:US14645730
申请日:2015-03-12
发明人: Andrew V. Halpert , Mark Tauscher
IPC分类号: A61M5/172
CPC分类号: A61M5/1723 , A61M2202/0496 , A61M2230/005
摘要: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
摘要翻译: 用于ADHF患者的流体治疗方法包括设定尿液输出速率期望阈值,设定一个或多个期望的负净增加率,以及可选地设定总体损失目标。 监测患者的尿量,并以增加的速率将流体自动施用于患者等于或大致匹配患者增加的尿量,直到患者的尿量达到设定的尿液输出速率期望阈值为止。 此后,以达到设定的所需负净增益率的速率向患者施用流体,直到达到流体损失目标。 此后,在治疗结束之前,将流体以等于或近似等于所监测的尿液输出率的速率施用于患者。
-
公开(公告)号:US20180338718A1
公开(公告)日:2018-11-29
申请号:US16053056
申请日:2018-08-02
摘要: A fluid replacement method including: determining the amount of urine expelled by a patient; infusing via a pump fluid from a first fluid source into a patient; determining an amount of fluid infused into the patient from the first fluid source; adjusting the operating of the pump based on the determined amount of urine expelled and the amount of fluid infused into the patient; setting a desired fluid balance for the patient; setting an amount of at least one additional fluid delivered to the patient, wherein the at least one additional fluid is not pumped into the patient; calculating an actual fluid balance based on the determined urine output, the determined amount of fluid infused into the patient from the first fluid source, and the set amount of said at least one additional fluid delivered to the patient; and automatically controlling the pump based on the actual fluid balance and the set desired fluid balance so the actual fluid balance conforms to the desired fluid balance.
-
公开(公告)号:US20180185577A9
公开(公告)日:2018-07-05
申请号:US14645730
申请日:2015-03-12
发明人: Andrew V. Halpert , Mark Tauscher , MARK GELFAND , HOWARD LEVIN
IPC分类号: A61M5/172
CPC分类号: A61M5/1723 , A61M2202/0496 , A61M2230/005
摘要: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
-
公开(公告)号:US20180071455A9
公开(公告)日:2018-03-15
申请号:US14645730
申请日:2015-03-12
发明人: Andrew V. Halpert , Mark Tauscher , MARK GELFAND , HOWARD LEVIN
IPC分类号: A61M5/172
CPC分类号: A61M5/1723 , A61M2202/0496 , A61M2230/005
摘要: A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.
-
-
-